Technical Analysis for IMMPF - Immupharma Plc

Grade Last Price % Change Price Change
grade B 0.18 5.88% 0.0100
IMMPF closed up 5.88 percent on Friday, July 24, 2020, on 1.39 times normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A N/A
Historical IMMPF trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week High Strength 0.00%
Gapped Up Strength 0.00%
Narrow Range Bar Range Contraction 5.88%
Gapped Up Strength 5.88%
New 52 Week Closing Low Bearish 28.57%
Narrow Range Bar Range Contraction 28.57%
New 52 Week Low Weakness 28.57%
Gapped Down Weakness 28.57%
Older signals for IMMPF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity, anti-infectives, metabolism, and cancer. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidate includes IPP-204106, a peptide to modulate angiogenesis with application in cancer and ophthalmology; and BioGlucagon a therapy for low sugar events in diabetes. ImmuPharma plc has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. The company was founded in 1999 and is headquartered in London, the United Kingdom.
Cancer Biopharmaceutical Diabetes Autoimmunity Peptide Hormones Ii Diabetes Peptide Anti Infectives Lupus

Is IMMPF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.18
52 Week Low 0.14
Average Volume 4,325
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0000
Average True Range 0.0000
ADX 0.0
+DI 0.0000
-DI 0.0000
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line 0.0000
MACD Signal Line 0.0000
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1800
Resistance 3 (R3) 0.1800 0.1800 0.1800
Resistance 2 (R2) 0.1800 0.1800 0.1800 0.1800
Resistance 1 (R1) 0.1800 0.1800 0.1800 0.1800 0.1800
Pivot Point 0.1800 0.1800 0.1800 0.1800 0.1800
Support 1 (S1) 0.1800 0.1800 0.1800 0.1800 0.1800
Support 2 (S2) 0.1800 0.1800 0.1800 0.1800
Support 3 (S3) 0.1800 0.1800 0.1800
Support 4 (S4) 0.1800